4.7 Article

The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy

期刊

CLINICAL MICROBIOLOGY AND INFECTION
卷 29, 期 7, 页码 863-875

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.cmi.2023.04.008

关键词

b-Lactam; Antibiotic allergy; Antimicrobial stewardship; Delabeling; Non-b-lactam antibiotics; Relabeling

向作者/读者索取更多资源

The Dutch Working Party on Antibiotic Policy (SWAB) established a multidisciplinary expert committee to provide evidence-based recommendations for antibiotic therapy in patients with reported antibiotic allergies. A total of 60 recommendations were generated for suspected allergy to β-lactam antibiotics (BLAs) and non-β-lactam antibiotics, based on systematic literature searches and evaluations.
Objectives: Prudent handling of reported antibiotic allergies is an important aspect of antibiotic stew-ardship. The Dutch Working Party on Antibiotic Policy (SWAB) constituted a multidisciplinary expert committee to provide evidence-based recommendations for bedside decision-making in antibiotic therapy in patients that report an antibiotic allergy. Methods: The guideline committee generated 12 key questions, most of which were population, inter-vention, comparison, and outcome questions relevant to both children and adults with suspected anti-biotic allergies. For each question, a systematic literature search was performed and reviewed for the best available evidence according to the Grading of Recommendations Assessment, Development and Eval-uation (GRADE) system. The quality of evidence was graded from very low to high, and recommendations were formulated in structured discussions as strong or weak. Results: Sixty recommendations were provided for suspected allergy to b-lactam antibiotics (BLAs) and non-b-lactam antibiotics. Owing to the absence of randomized controlled trials in this field, the un-derlying evidence was predominantly graded as low or very low. Available data support that a detailed allergy history should always be performed and critically appraised. When cross-allergy between BLA groups is not to be expected due to the absence of molecular similarity of the side chains, the patient can be safely exposed to the alternative BLA. An exception to this rule is severe delayed-type reactions in which re-exposure to a BLA should only be considered after consultation with a multidisciplinary team. Conclusions: Accumulated scientific data now support a more liberal approach that better balances the benefits of treatment with first choice and usually smaller spectrum antibiotics with appropriate avoidance of antibiotics in case of a truly high risk of a (severe) allergic reaction. In The Netherlands, a formal guideline was developed that provides recommendations for the approach toward suspected

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据